Laman UtamaHDP1 • FRA
add
Arrowhead Pharmaceuticals Inc
Tutup sebelumnya
€53.58
Julat hari
€53.06 - €54.02
Julat tahun
€8.85 - €64.14
Permodalan pasaran
8.86B USD
Bilangan Purata
72.00
Nisbah P/E
-
Hasil dividen
-
Pertukaran utama
NASDAQ
Berita pasaran
Kewangan
Penyata Pendapatan
Hasil
Pendapatan bersih
| (USD) | Dis 2025info | Perubahan T/T |
|---|---|---|
Hasil | 264.03J | 10,461.32% |
Perbelanjaan pengendalian | 223.22J | 36.19% |
Pendapatan bersih | 30.81J | 117.80% |
Margin untung bersih | 11.67 | 100.17% |
Pendapatan bagi setiap syer | 0.22 | 115.83% |
EBITDA | 47.20J | 130.22% |
Kadar cukai berkesan | 0.10% | — |
Kunci Kira-kira
Jumlah aset
Jumlah liabiliti
| (USD) | Dis 2025info | Perubahan T/T |
|---|---|---|
Pelaburan tunai dan jangka pendek | 914.71J | 66.06% |
Jumlah aset | 1.60B | 58.25% |
Jumlah liabiliti | 1.04B | 8.76% |
Jumlah ekuiti | 562.70J | — |
Syer tertunggak | 140.03J | — |
Harga kepada buku | 12.94 | — |
Pulangan pada aset | 6.83% | — |
Pulangan pada modal | 8.13% | — |
Aliran Tunai
Perubahan bersih dalam tunai
| (USD) | Dis 2025info | Perubahan T/T |
|---|---|---|
Pendapatan bersih | 30.81J | 117.80% |
Tunai daripada operasi | 13.48J | 109.22% |
Tunai daripada pelaburan | -23.74J | -130.87% |
Tunai daripada pembiayaan | -14.75J | -171.48% |
Perubahan bersih dalam tunai | -24.90J | 48.96% |
Aliran tunai bebas | -39.86J | 65.17% |
Perihal
Arrowhead Pharmaceuticals, Inc. is a publicly traded biopharmaceutical company based in Pasadena, California. Arrowhead's products in development act through RNA interference mechanisms of action. The company focuses on treatments for hepatitis B, liver disease associated with alpha 1-antitrypsin deficiency and cardiovascular disease. Wikipedia
Diasaskan
1 Jan 2004
Ibu pejabat
Tapak web
Pekerja
711
